Page 345 - கடுமையானது எடுப்போசை சுவாச நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In contrast to vaccines against SARS-CoV-2, we really don t have many drugs that are effective against the virus. This is an exciting result that identifies MK-4482 as an additional antiviral against SARS-CoV-2,” said Michael Jarvis, associate professor of Virology and Immunology at the University of Plymouth and a guest researcher at NIH. “The drug, also called Molnupiravir, is in the final stages of human clinical trials in SARS-CoV-2 infected patients.” If human data shows a similar antiviral effect, it may be suitable for use as an orally administered pill following exposure to the virus, similar to the way Tamiflu is used for influenza, the researchers said.

Michael jarvisNational institutes of healthDrug administrationNature communications onUniversity of plymouthNational institutesNature communicationsJubilant pharmaMiddle east respiratory syndromeSevere acute respiratory syndromeCorona virusCovid 19Sars cov 2Oral drugமைக்கேல் ஜார்விஸ்தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்